NewAmsterdam Pharma Co N.V.
NAMS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001936258
In the last 90 days, NewAmsterdam Pharma Co N.V. insiders filed 1 open-market purchase and 3 sales; 194 institutions reported holding it in 13F filings for Q2 2026, worth $4.13B in total; 3 superinvestors hold it, including Viking Global Investors and Maverick Capital.
Other share classesNAMSW
13F holders, Q2 2023
Institutional positions in NewAmsterdam Pharma Co N.V. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 29
- +10 vs. Q1 2023
- Shares held
- 48.8M
- +15.5M (+46.4%) vs. Q1 2023
- Total value
- $580.6M
- +$135.8M (+30.5%) vs. Q1 2023
- New holders
- 11
- 13 more added
- Sold out
- 1
- 1 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NAMS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 194 | $4.13B |
| Q1 2026 | 171 | $3.96B |
| Q4 2025 | 187 | $4.19B |
| Q3 2025 | 137 | $3.43B |
| Q2 2025 | 131 | $2.11B |
| Q1 2025 | 126 | $2.28B |
| Q4 2024 | 131 | $2.53B |
| Q3 2024 | 100 | $1.28B |
| Q2 2024 | 90 | $1.38B |
| Q1 2024 | 76 | $1.71B |
| Q4 2023 | 32 | $691.4M |
| Q3 2023 | 35 | $464.1M |
| Q2 2023 | 29 | $580.6M |
| Q1 2023 | 19 | $444.9M |
| Q4 2022 | 14 | $362.2M |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding NewAmsterdam Pharma Co N.V.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 10,871,803 | $129.3M | 7.72% | +1,530,252+16.4% | Added |
| Bain Capital Life Sciences Investors, LLC | 10,473,913 | $124.5M | 12.83% | +2,173,913+26.2% | Added |
| Ra Capital Management, L.P. | 9,000,000 | $107.0M | 2.02% | +5,000,000+125.0% | Added |
| Viking Global Investors LPSuperinvestorViking Global Investors | 6,524,565 | $77.6M | 0.32% | +2,608,695+66.6% | Added |
| Medicxi Ventures Management (Jersey) Ltd | 2,869,565 | $34.1M | 9.56% | +869,565+43.5% | Added |
| Deerfield Management Company, L.P. (Series C) | 2,535,723 | $30.1M | 0.64% | 00.0% | Unchanged |
| BVF Inc | 1,521,948 | $18.1M | 0.50% | 00.0% | Unchanged |
| GMT Capital Corp | 1,383,800 | $16.5M | 0.62% | +300,000+27.7% | Added |
| Adage Capital Partners GP, L.L.C. | 1,200,000 | $14.3M | 0.03% | +1,200,000 | New |
| Eversept Partners, LP | 692,369 | $8.23M | 0.87% | +646,513+1,409.9% | Added |
| Ensign Peak Advisors, Inc | 441,956 | $5.25M | 0.01% | +86,956+24.5% | Added |
| Millennium Management LLC | 373,552 | $4.44M | 0.00% | +317,919+571.5% | Added |
| Parkman Healthcare Partners LLC | 239,051 | $2.84M | 0.49% | +124,051+107.9% | Added |
| AXA S.A. | 224,351 | $2.67M | 0.01% | +224,351 | New |
| Alyeska Investment Group, L.P. | 129,547 | $1.54M | 0.01% | +129,547 | New |
| Affinity Asset Advisors, LLC | 100,000 | $1.19M | 0.47% | +100,000 | New |
| Monashee Investment Management LLC | 95,000 | $1.13M | 0.27% | +95,000 | New |
| Schonfeld Strategic Advisors LLC | 57,300 | $681.3K | 0.01% | +27,200+90.4% | Added |
| Geode Capital Management, LLC | 25,768 | $306.4K | 0.00% | +7,209+38.8% | Added |
| Marshall Wace, LLP | 25,361 | $301.5K | 0.00% | +25,361 | New |
| Maven Securities LTD | 25,000 | $297.3K | 0.04% | +25,000 | New |
| JPMorgan Chase & Co | 11,463 | $136.3K | 0.00% | −10,904−48.8% | Reduced |
| Venture Visionary Partners LLC | 10,000 | $118.9K | 0.01% | +10,000 | New |
| Morgan Stanley | 808 | $9.61K | 0.00% | +305+60.6% | Added |
| Cutler Group LP | 500 | $5.00K | 0.00% | +500 | New |
| Wells Fargo & Company | 300 | $3.57K | 0.00% | +300 | New |
| UBS Group AG | 183 | $2.18K | 0.00% | +183 | New |
| Atticus Wealth Management, LLC | 166 | $1.97K | 0.00% | 00.0% | Unchanged |
| DuPont Capital Management Corp | 1 | $12 | 0.00% | 00.0% | Unchanged |
| Wolverine Asset Management LLC | 0 | $0 | 0.00% | −4,819−100.0% | Sold out |